| 摘要 |
Benzimidazole derivatives of Formula I or a pharmaceutically acceptable salt thereof are MCP-1 antagonists and are thus useful in the treatment of inflammation, atherosclerosis, restenosis, and immune disorderswherein A is N or CH;where W, X, Y, and Z can be independently C-R2, C-R3, C-R4, C-R5, or N;no more than two of W, X, Y, and Z can be N in any one structure,R2, R3, R4, and R5 are as define in the specification.
|
